Health Condition 1: null- ASA grade I and II patients scheduled for surgeries Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: dexmedetomidine: 0.5 mcg/kg body weight dexmedetomidine given slow intravenously in 100 ml NS
Control Intervention1: tramadol: tramadol 1 mg/kg body weight given slow intravenously in
Sponsors
St Stephens hospital Tis Hazari Delhi
Eligibility
Inclusion criteria
Inclusion criteria: Patients having ASA grade I and II. Patients aged 18 - 65 years. Patients who are scheduled to undergo lower abdominal and lower limb surgeries.
Exclusion criteria
Exclusion criteria: Patients who are not willing to give consent for participation in the study. Patients who require duration of surgery > 2 hrs. Patients with contraindication to central neuraxial blockade. Patients with ASA grade III and IV. Patients with suspected autonomic dysfunction. Patients with hypersensitivity to tramadol,dexmedetomidine. Patients with cardiopulmonary,renal or hepatic diseases,hyperparathyroidism,psychiatric disorder,urinary tract infection,severe diabetes or autonomic neuropathies. Patients with known history of substance or alcohol abuse. Patients receiving any premedication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time of cessation of shivering after treatment with dexmedetomidine and tramadol in perioperative shivering after subarachnoid blockTimepoint: Time of cessation of shivering after giving the drug | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in clinical parameters( HR,NIBP,SPO2 ) during treatment of shivering in both groups and side effects,if any,of the respective drugsTimepoint: every 5 minutes till 30minutes, then every 10 minutes till 60 minutes. | — |
Countries
India
Contacts
Public ContactDr Shivangi Ganjoo
St. Stephens Hospital , Tis Hazari ,Delhi
Outcome results
None listed